You have 9 free searches left this month | for more free features.

Carboplatin

Showing 1 - 25 of 3,039

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • HLX10 + chemotherapy (carboplatin-etoposide)
  • Atezolizumab + chemotherapy (carboplatin-etoposide)
  • (no location specified)
Jul 19, 2022

Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 31, 2022

Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Carboplatin
  • Groningen, Netherlands
  • +3 more
Aug 19, 2022

NSCLC Trial in Seoul (Atezolizumab(Tecentriq), Pemetrexed, Bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Gangnamgu, Korea, Republic of
    Samsung Medical Center
Dec 27, 2021

METASTATIC CERVICAL CANCER Trial (QL1706, Placebo)

Not yet recruiting
  • METASTATIC CERVICAL CANCER
  • (no location specified)
Jun 30, 2022

Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Breast Cancer Trial in New York (Carboplatin, Everolimus)

Recruiting
  • Breast Cancer
  • New York, New York
  • +2 more
Oct 22, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Seattle

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Carboplatin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 10, 2022

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Carboplatin
  • +3 more
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Bevacizumab and Carboplatin
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)

Recruiting
  • Lung Adenocarcinoma
  • Cryotherapy Effect
  • Cryoablation
  • +3 more
  • Bordeaux, Gironde, France
    Institut Bergonié
Oct 29, 2021

Head and Neck Squamous Cell Carcinoma Trial in Seoul (paclitaxel/carboplatin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 24, 2022

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • Carboplatin
  • (no location specified)
Jun 22, 2022

Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)

Active, not recruiting
  • Breast Cancer
  • Cincinnati, Ohio
  • +2 more
Apr 6, 2022

Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

Recruiting
  • Castration-resistant Prostate Cancer
  • Homologous Recombination Deficiency
  • Testosterone Enanthate 100 MG/ML Injectable Solution
  • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Oct 19, 2021

NSCLC(NSCLC) Trial in Nanjing (BP102, paclitaxel, carboplatin, Avastin®, paclitaxel, carboplatin)

Completed
  • Non-small Cell Lung Cancer(NSCLC)
  • BP102, paclitaxel, carboplatin
  • Avastin®, paclitaxel, carboplatin
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Dec 23, 2021

Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

Completed
  • Metastatic Medulloblastoma
  • +2 more
  • Carboplatin
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 13, 2021

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Triple Negative Breast Cancer Trial in Shijiazhuang (Albumin bound (nab)-paclitaxel combined with carboplatin followed by

Withdrawn
  • Triple Negative Breast Cancer
  • Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide
  • paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Jul 6, 2021

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Carboplatin
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Fallopian Tube Cancer, Peritoneum Cancer, Epithelial Ovarian Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Miami, Florida
    University of Miami
Dec 24, 2021

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Carboplatin
  • (no location specified)
Jul 11, 2022